Anti-IgM-activation of CLL cells causes them to take up more glucose and increase their expression of glucose transporters and key glycolytic enzymes such as HK2, with the extent of these metabolic alterations reflected by levels of initial calcium flux. Here, CD40LG is linked to B-cell chronic lymphocytic leukemia.